Autophagy and radiosensitization in cancer

por Sharma, Khushboo, Goehe, Rachel, Beckta, Jason M., Valerie, Kristoffer, Gewirtz, David A.
Publicado 2014

American Society of Clinical Oncology 2022 Annual Meeting Highlights for Radiation Oncologists

por Dove, Austin P.H., Ryckman, Jeffrey, Chhabra, Arpit, Beckta, Jason, Chowdhary, Mudit
Publicado 2022

An Evaluation of Health Numeracy among Radiation Therapists and Dosimetrists

por Peters, Gabrielle W., Kelly, Jacqueline R., Beckta, Jason M., White, Marney, Marks, Lawrence B., Ford, Eric, Evans, Suzanne B.
Publicado 2020

Genetic characterization of a case of sellar metastasis from bronchial carcinoid neuroendocrine tumor

por Christopher S, . Hong, Kundishora, Adam J., Elsamadicy, Aladine A., Koo, Andrew B., Beckta, Jason M., McGuone, Declan, Erson-Omay, E. Zeynep, Omay, Sacit Bulent
Publicado 2020

Unsealed Source: Scope of Practice for Radiopharmaceuticals Among United States Radiation Oncologists

por Shukla, Utkarsh, Chowdhury, Imran H., Beckta, Jason M., Witt, Jacob S., McFarlane, Matthew, Miller, Chelsea J., Huber, Kathryn E., Katz, Matthew S., Royce, Trevor J., Chowdhary, Mudit
Publicado 2021

Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining

por Beckta, Jason M., Dever, Seth M., Gnawali, Nisha, Khalil, Ashraf, Sule, Amrita, Golding, Sarah E., Rosenberg, Elizabeth, Narayanan, Aarthi, Kehn-Hall, Kylene, Xu, Bo, Povirk, Lawrence F., Valerie, Kristoffer
Publicado 2015

Correction: Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining

por Beckta, Jason M., Dever, Seth M., Gnawali, Nisha, Khalil, Ashraf, Sule, Amrita, Golding, Sarah E., Rosenberg, Elizabeth, Narayanan, Aarthi, Kehn-Hall, Kylene, Xu, Bo, Povirk, Lawrence F., Valerie, Kristoffer
Publicado 2016

Persistent STAG2 mutation despite multimodal therapy in recurrent pediatric glioblastoma

por Hong, Christopher S., Vasquez, Juan C., Kundishora, Adam J., Elsamadicy, Aladine A., Beckta, Jason M., Sule, Amrita, Marks, Asher M., Leelatian, Nalin, Huttner, Anita, Bindra, Ranjit S., DiLuna, Michael L., Kahle, Kristopher T., Erson-Omay, E. Zeynep
Publicado 2020

Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity

por Gayle, Sophia, Aiello, Robert, Leelatian, Nalin, Beckta, Jason M, Bechtold, Jane, Bourassa, Patricia, Csengery, Johanna, Maguire, Robert J, Marshall, Dan, Sundaram, Ranjini K, Van Doorn, Jinny, Jones, Kelli, Moore, Hunter, Lopresti-Morrow, Lori, Paradis, Timothy, Tylaska, Laurie, Zhang, Qing, Visca, Hannah, Reshetnyak, Yana K, Andreev, Oleg A, Engelman, Donald M, Glazer, Peter M, Bindra, Ranjit S, Paralkar, Vishwas M
Publicado 2021

Correction to ‘Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity’

por Gayle, Sophia, Aiello, Robert, Leelatian, Nalin, Beckta, Jason M, Bechtold, Jane, Bourassa, Patricia, Csengery, Johanna, Maguire, Robert J, Marshall, Dan, Sundaram, Ranjini K, Van Doorn, Jinny, Jones, Kelli, Moore, Hunter, Lopresti-Morrow, Lori, Paradis, Timothy, Tylaska, Laurie, Zhang, Qing, Visca, Hannah, Reshetnyak, Yana K, Andreev, Oleg A, Engelman, Donald M, Glazer, Peter M, Bindra, Ranjit S, Paralkar, Vishwas M
Publicado 2021